Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8% Arginine toothpaste for dentinal hypersensitivity
NCT07257042Phase 3Completed
- Sponsor
- Colgate-Palmolive
- Start
- Jul 2025
- Primary completion
- Nov 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of arginine in Dentinal hypersensitivity (DH) (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Tactile Hypersensitivity measured by Yeaple Probe at 8 weeks and Air Blast Hypersensitivity measured by Schiff Cold Air Sensitivity Scale at 8 weeks. Started Jul 2025; status: completed.
02
Drugs
arginine
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on NCT07257042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257042.